Download PDF
Kinder- und Jugendmedizin 2004; 04(01): 15-24
DOI: 10.1055/s-0037-1617806
Onkologie
Schattauer GmbH

Schmerztherapie in der pädiatrischen Onkologie

Pain management in paediatric oncology
Christine Wamsler
1   Vestische Kinder- und Jugendklinik Datteln, Universität Witten/Herdecke (Direktor: Dr. med. W. Andler)
,
Boris Zernikow
1   Vestische Kinder- und Jugendklinik Datteln, Universität Witten/Herdecke (Direktor: Dr. med. W. Andler)
› Author Affiliations
Further Information

Publication History

Publication Date:
12 January 2018 (online)

    Permissions and Reprints

Zusammenfassung

Schmerzen begleiten das krebskranke Kind im gesamten Verlauf seiner Erkrankung und stellen nicht selten eine bedeutende Einschränkung der Lebensqualität dar. In den allermeisten Fällen lassen sich auch schwere Schmerzen durch eine rationale Schmerztherapie beherrschen. Unabdingbare Voraussetzung dafür sind eine ausführliche Schmerzanamnese und die kontinuierliche Schmerzmessung und Dokumentation.

Die medikamentöse Schmerzbehandlung erfolgt nach dem WHO-Stufenschema, wobei sich die Notwendigkeit zu Modifikationen ergeben kann. Adjuvante Medikamente und nichtmedikamentöse Therapiemöglichkeiten ergänzen einen umfassenden Therapieansatz. Therapienebenwirkungen müssen antizipiert und behandelt werden.

Besondere Probleme wie Mukositis, neuropathische Schmerzen, Knochenschmerzen und Schmerzen in der Lebensendphase erfordern individuelle und flexible Therapieansätze.

Eine unzureichende Schmerztherapie gründet meist in verzögertem Beginn, zu niedrigen Dosierungen, fehlender Titration am Schmerz, d. h. zu zögerlicher Dosissteigerung besonders bei starken Schmerzen.

Summary

Pain accompanies a child with cancer during the whole course of his or her disease and it often causes a major loss of quality of life for the child. With very few exceptions an effective pain management can control severe pain. Taking the pain history, continuous pain assessment and documentation are major hallmarks to achieve this.

The optimal drug pain relief therapy follows the WHO-three-step analgesic ladder with possible modifications in individual cases. Adjuvant drugs and non-drug pain management add up to a comprehensive base of pain relief therapy. Side effects should be anticipated and treated. Particular problems such as mucositis, neuropathic pain, bone pain or pain in the end-of-life-period need individual and flexible management. An inadequate pain management is usually caused by delaying the initiation of pain relief therapy, insufficient dosage, and insufficient titration, i. e. inadequate increment of dosage especially in case of severe pain.

Schlüsselwörter

Schmerztherapie - pädiatrische Onkologie - Opioide

Keywords

Pain management - paediatric oncology - opioids
 

  • Literatur

  • 1 Collins JJ, Berde CB. Intravenous amitryptiline in pediatrics. J Pain Symptom Manag 1995; 10: 471-5.
    CrossrefPubMedGoogle Scholar
  • 2 Collins JJ. Intractable pain in children with terminal cancer. J palliativ Care 1996; 12: 29-34.
    Google Scholar
  • 3 Collins JJ, Grier HE, Sethna NF, Wilder RT, Berde CB. Regional anesthesia for pain associated with terminal malignancy. Pain 1996; 65: 63-9.
    CrossrefPubMedGoogle Scholar
  • 4 Collins JJ, Byrnes ME, Dunkel IJ. et al. The measurement of symptoms in children with cancer. J Pain Symptom Manag 2000; 19: 363-77.
    CrossrefPubMedGoogle Scholar
  • 5 Dangel T. Chronic pain mangement in children. Part I: cancer and phantom pain. Pediatr Anaesth 1998; 8: 5-10.
    CrossrefPubMedGoogle Scholar
  • 6 Doyle E, Morton NS, McNicol LR. Comparison of patient – controlled analgesia in children by iv and sc routes of administration. Br J Anaesth 1994; 72: 533-6.
    CrossrefPubMedGoogle Scholar
  • 7 Gaukroger PB. Patient controlled analgesia in children. In: Schechter NL, Berde CB, Yaster M. (eds). Pain in infants, children and adolescents. Baltimore: Williams & Wilkins; 1993: 203-12.
    Google Scholar
  • 8 Gaukroger PB, Tomkins DP, Walt JH. van der Patient controlled analgesia in children. Anaesth Intensive Care 1989; 17: 10-4.
    Google Scholar
  • 9 Hilden JM, Emanuel EJ, Fairclough DL, Link MP, Foley KM, Clarridge BC, Schnipper LE, Mayer RJ. Attitudes and Practices Among Pediatric Oncologists Regarding End-of-Life Care: Results of the 1998 American Society of Clinical Oncology Survey. J Clinic Oncol 2001; 19: 205-12.
    CrossrefPubMedGoogle Scholar
  • 10 Jacobs H, Rister M. Die Fremdeinschätzung von Schmerzen bei Kindern. Klin Paediatr 1997; 209: 384-8.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Leman M, Chaussade S, Halphen M, Floune B, Morcau J, Bommelaer G, Attar A. Low-dose polyethylene glycol (PEG) in chronic obstipation: double-blind, placebo- controlled, crossover trial. Gastroenterology 1996; 110: A704.
    Google Scholar
  • 12 Lloyd-Thomas AR, Howard RF, Llewellyn N. The management of acute and postoperative pain in infancy and childhood. In: Aynsley Green A, Ward Platt MP, Lloyd-Thomas AR. (eds). Bailliere’s clinical pediatrics. International practice and resea. Stress and pain in infancy and childhood. London: Bailliere Tindal; 1995: 579-600.
    Google Scholar
  • 13 McGrath P, Hsu E, Cappelli M, Luke B, Goodman J, Dunn-Geier J. Pain from pediatric cancer: a survey of an outpatient oncology clinic. J Psychosoc Oncol 1990; 8: 109-24.
    CrossrefGoogle Scholar
  • 14 McGrath PJ, Beyer J, Cleeland C, Eland J, McGrath PA, Portenoy R. Report of the consensus conference on the mangement of pain in childhood cancer. Report of the subcommittee on assessment and methodological issues in the management of pain in childhood cancer. Pediatrics 1990; 5 (Suppl. 02) 814-7.
    Google Scholar
  • 15 McGrath PJ. Pain in children: Nature, assessment and treatment. Controlling children’s pain: a practical approach to assessment and management. New York: Guilford; 1990
    Google Scholar
  • 16 McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. Pain 1996; 68: 217-27.
    CrossrefPubMedGoogle Scholar
  • 17 Mercadante S. Malignant bone pain: pathophysiology and treatment. Pain 1997; 69: 1-18.
    CrossrefPubMedGoogle Scholar
  • 18 Miser AW, Dothage JA, Wesley RA. et al. The prevalence of pain in pediatric and young adult cancer population. Pain 1987; 29: 73-83.
    CrossrefPubMedGoogle Scholar
  • 19 Patel RI, Davis PJ, Orr RJ. Single-dose ondansetron prevents postoperative vomiting in pediatric outpatients. Anesth Analg 1996; 85: 538-45.
    Google Scholar
  • 20 Ragg P. Opioids in children. In: McKenzie IM, Gaukroger PB, Ragg PC, Brown TCK. (eds). Manual of acute pain management in children. New York: Churchill, Livingston; 1997: 25-38.
    Google Scholar
  • 21 Reimann J. Kauend gegen Kinetosen. Dtsch Apotheker Z 1983; 123: 898-9.
    Google Scholar
  • 22 Sirkiä K, Hovi L, Pouttu J, Saarinen Pihkala UM. Pain medication during terminal care of children with cancer. J Pain Symptom Manage 1998; 15: 220-6.
    CrossrefPubMedGoogle Scholar
  • 23 Sittl R, Huber H, Griessinger N, Richter R, Sorge J. Grundlagen der Tumorschmerztherapie bei Kindern und Jugendlichen. In: Maier U, Kaiser R, Moir CR. (Hrsg). Schmerz beim Kind. Berlin, Heidelberg, New York, Tokio: Springer; 1993: 41-9.
    Google Scholar
  • 24 Sümpelmann R, Schröder D, Krohn S, Strauß JM, Hausdörfer J. Patientenkontrollierte Analgesie bei Kindern. Anästh Intensivmed 1996; 1: 19-26.
    Google Scholar
  • 25 Tobias JD, Martin LD, Wetzel RC. Ketamine by continuous infusion for sedation in the pediatric intensive care unit. Crit Care Med 1990; 18: 819-21.
    CrossrefPubMedGoogle Scholar
  • 26 Van Hoogdalem EJ, Boer AG de, Breimer DD. Pharmacokinetics of rectal drug administration. Clin Pharmacokinet 1991; 21: 11-26.
    CrossrefPubMedGoogle Scholar
  • 27 Vargas-Schaffer G, Pichard-Leandri E. Neuropathic pain in young children with cancer. Eur J Palliat care 1997; 15: 19-25.
    Google Scholar
  • 28 Westlin JE, Letocha H, Jakobson A, Martinsson U, Nilsson S. Rapid, reproducible pain relief with 131Jod-MIBG in a boy with disseminated neuroblastoma. Pain 1995; 60: 111-4.
    CrossrefPubMedGoogle Scholar
  • 29 Wolfe J, Grier HE, Klar N, Levin SB, Ellbogen JM, Salem-Schatz S, Emanuel EJ, Weeks JC. Symptoms and suffering at the end of life in children with cancer. N Engl J Med 2000; 342: 326-33.
    CrossrefPubMedGoogle Scholar
  • 30 World Health Organization, deutsche Ausgabe 2001. Schmerztherapie und palliative Versorgung krebskranker Kinder. Vestische Kinderklinik Datteln – Universität Witten/Herdecke; 1998. (Hrsg der deutschen Ausgabe).
    Google Scholar
  • 31 Zeltzer LK, Altman A, Cohen D, LeBaron S, Maunuksela L, Schechter NL. Report of the consensus conference on the management of pain in childhood cancer. Report of the subcommittee on the management of pain associated with procedures in children with cancer. Pediatrics 1990; 5 (Suppl. 02) 826-31.
    Google Scholar
  • 32 Yaster M, Krane EJ, Kaplan RF, Cote CJ, Lappe DG. Pediatric pain and sedation handbook. St Louis: Mosby; 1997
    Google Scholar
  • 33 Zernikow B, Grießinger N, Fengler R. Schmerz – Therapie in der onkologischen Pädiatrie. Praktische Schmerztherapie in der Kinderonkologie. Monatsschr Kinderheilkd 1999; Sonderdruck 5/99..
    Google Scholar
  • 34 Zernikow B. Schmerztherapie in der Kinderhämatoonkologie. In: Zernikow B. Schmerztherapie bei Kindern. Berlin, Heidelberg, New York, Tokio: Springer; 2001: 176-208.
    Google Scholar
  • 35 Zernikow B, Bauer AG, Andler W. Schmerztherapie in der pädiatrischen Onkologie – eine Bestandsaufnahme. Der Schmerz 2001; 16: 140-9.
    Google Scholar
  • 36 Zernikow B, Lindena G. Long acting morphine for pain control in pediatric oncology. Med Ped Oncol 2001; 36: 451-8.
    CrossrefPubMedGoogle Scholar
  • 37 Zernikow B, Bauer AG, Andler W. STOP – a nationwide quality improvement program of pain control in pediatric oncology. 5th Int Symp Paediatric Pain. London: 2000. June 18-21.
    Google Scholar